Valent BioSciences LLC, began selling biostimulant products directly to its U.S. customer base on Oct 1.
The new operating unit was established in February 2022 and it is now fully operational, enabling the organization to serve the entire U.S market. The announcement marks a change in the market strategy for Valent BioSciences.
The new biostimulant business team and salesforce are focused on discovering, developing, and commercializing arbuscular mycorrhizal fungi products, among other biostimulants, to sustainably maximize retailer and grower profitability.
“As both market volatility and the global population increase, biostimulants can be used to sustainably improve crop performance and ROI,” said Salman Mir, Executive Vice President and Chief Operating Officer at Valent BioSciences.
The core Valent BioSciences biostimulant products are being marketed under the Symvado and Proliant brand names. The company will be employing a variety of newly created tools and digital assets to support commercialization of these brands in the U.S. market.
More information about Valent BioSciences products is available by phone at 877-696-4204 or email email@example.com.